Michael L. Linenberger
Division of Hematology and Department of Medicine
University of Washington
USA
Name/email consistency: high
- Catheter-related thrombosis: risks, diagnosis, and management. Linenberger, M.L. J. Natl. Compr. Canc. Netw (2006)
- CD33-directed therapy with gemtuzumab ozogamicin in acute myeloid leukemia: progress in understanding cytotoxicity and potential mechanisms of drug resistance. Linenberger, M.L. Leukemia (2005)
- Use of cellular and plasma apheresis in the critically ill patient: part 1: technical and physiological considerations. Linenberger, M.L., Price, T.H. J. Intensive. Care. Med (2005)
- Use of cellular and plasma apheresis in the critically ill patient: Part II: Clinical indications and applications. Linenberger, M.L., Price, T.H. J. Intensive. Care. Med (2005)
- Thromboembolic complications of malignancy. Part 2: management. Linenberger, M.L., Wittkowsky, A.K. Oncology (Williston Park, N.Y.) (2005)
- Antibody-directed therapies for hematological malignancies. Linenberger, M.L., Maloney, D.G., Bernstein, I.D. Trends. Mol. Med (2002)
- Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicin. Linenberger, M.L., Hong, T., Flowers, D., Sievers, E.L., Gooley, T.A., Bennett, J.M., Berger, M.S., Leopold, L.H., Appelbaum, F.R., Bernstein, I.D. Blood (2001)
- Fibrinogen bellingham: a gamma-chain R275C substitution and a beta-promoter polymorphism in a thrombotic member of an asymptomatic family. Linenberger, M.L., Kindelan, J., Bennett, R.L., Reiner, A.P., Côté, H.C. Am. J. Hematol. (2000)
- Lymphokines modulate the growth and survival of thymic tumor cells containing a novel feline leukemia virus/Notch2 variant. Linenberger, M.L., Rohn, J.L., Deng, T., Ellis-Smith, S., Ingber, R., Overbaugh, J. Vet. Immunol. Immunopathol. (1999)
- The effects of feline retroviruses on cytokine expression. Linenberger, M.L., Deng, T. Vet. Immunol. Immunopathol. (1999)









